204 related articles for article (PubMed ID: 18501527)
1. The M. D. Anderson symptom inventory-head and neck module, a patient-reported outcome instrument, accurately predicts the severity of radiation-induced mucositis.
Rosenthal DI; Mendoza TR; Chambers MS; Burkett VS; Garden AS; Hessell AC; Lewin JS; Ang KK; Kies MS; Gning I; Wang XS; Cleeland CS
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1355-61. PubMed ID: 18501527
[TBL] [Abstract][Full Text] [Related]
2. M. D. Anderson symptom inventory head neck (MDASI-HN) questionnaire: Italian language psychometric validation in head and neck cancer patients treated with radiotherapy ± systemic therapy - A study of the Italian Association of Radiotherapy and Clinical Oncology (AIRO).
Viganò A; De Felice F; Iacovelli NA; Alterio D; Facchinetti N; Oneta O; Bacigalupo A; Tornari E; Ursino S; Paiar F; Caspiani O; Di Rito A; Musio D; Bossi P; Steca P; Jereczek-Fossa BA; Greco A; Orlandi E
Oral Oncol; 2021 Apr; 115():105189. PubMed ID: 33549926
[TBL] [Abstract][Full Text] [Related]
3. Nomogram for predicting symptom severity during radiation therapy for head and neck cancer.
Sheu T; Fuller CD; Mendoza TR; Garden AS; Morrison WH; Beadle BM; Phan J; Frank SJ; Hanna EY; Lu C; Cleeland CS; Rosenthal DI; Gunn GB
Otolaryngol Head Neck Surg; 2014 Oct; 151(4):619-26. PubMed ID: 25104816
[TBL] [Abstract][Full Text] [Related]
4. Psychometric Validation of the M. D. Anderson Symptom Inventory-Head and Neck Module in the Spanish Language.
Sánchez D; Chala A; Alvarez A; Payan C; Mendoza T; Cleeland C; Sanabria A
J Pain Symptom Manage; 2016 Jun; 51(6):1055-61. PubMed ID: 26899822
[TBL] [Abstract][Full Text] [Related]
5. Italian version of the M.D. Anderson Symptom Inventory--Head and Neck Module: linguistic validation.
Greco A; Orlandi E; Mirabile A; Takanen S; Fallai C; Iacovelli NA; Rimedio A; Russi E; Sala M; Monzani D; Rosenthal DI; Gunn GB; Steca P; Licitra L; Bossi P
Support Care Cancer; 2015 Dec; 23(12):3465-72. PubMed ID: 25791393
[TBL] [Abstract][Full Text] [Related]
6. Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck module.
Rosenthal DI; Mendoza TR; Chambers MS; Asper JA; Gning I; Kies MS; Weber RS; Lewin JS; Garden AS; Ang KK; S Wang X; Cleeland CS
Head Neck; 2007 Oct; 29(10):923-31. PubMed ID: 17358040
[TBL] [Abstract][Full Text] [Related]
7. Patient reported dry mouth: Instrument comparison and model performance for correlation with quality of life in head and neck cancer survivors.
; Kamal M; Rosenthal DI; Volpe S; Goepfert RP; Garden AS; Hutcheson KA; Al Feghali KA; Meheissen MAM; Eraj SA; Dursteler AE; Williams B; Smith JB; Aymard JM; Berends J; White AL; Frank SJ; Morrison WH; Cardoso R; Chambers MS; Sturgis EM; Mendoza TR; Lu C; Mohamed ASR; Fuller CD; Gunn GB
Radiother Oncol; 2018 Jan; 126(1):75-80. PubMed ID: 29229507
[TBL] [Abstract][Full Text] [Related]
8. Psychometric validation of the Chinese version of the M. D. Anderson Symptom Inventory-Head and Neck Module in patients with nasopharyngeal carcinoma.
Xiao W; Chan CWH; Wang XS; Xiao J; Ng MSN
Asia Pac J Oncol Nurs; 2022 Feb; 9(2):113-118. PubMed ID: 35529413
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal evaluation of the oral mucositis weekly questionnaire-head and neck cancer, a patient-reported outcomes questionnaire.
Epstein JB; Beaumont JL; Gwede CK; Murphy B; Garden AS; Meredith R; Le QT; Brizel D; Isitt J; Cella D
Cancer; 2007 May; 109(9):1914-22. PubMed ID: 17377917
[TBL] [Abstract][Full Text] [Related]
10. Validation of the MD Anderson Symptom Inventory-Head-and-Neck-Filipino (MDASI-HN-F): clinical utility of symptom screening among patients with head-and-neck cancer.
Bacorro WR; Sy Ortin TT; Suarez CG; Mendoza TR; Que JC
BMJ Support Palliat Care; 2017 Jun; 7(2):140-149. PubMed ID: 25941198
[TBL] [Abstract][Full Text] [Related]
11. Linguistic validation of the Greek M.D. Anderson Symptom Inventory - Head and Neck Module.
Gunn GB; Koukourakis MI; Mendoza TR; Cleeland CS; Rosenthal DI
Forum Clin Oncol; 2012 Mar; 3(1):29-31. PubMed ID: 23439668
[TBL] [Abstract][Full Text] [Related]
12. Comparing the M.D. Anderson Symptom and Dysphagia Inventories for Head and Neck Cancer Patients.
Yarschenko AH; Yannitsos DH; Weppler S; Barbera L; Quon H; Sun Q; Smith W
Laryngoscope; 2022 Dec; 132(12):2388-2395. PubMed ID: 35247215
[TBL] [Abstract][Full Text] [Related]
13. Linguistic Validation of the Turkish Version of the M.D. Anderson Symptom Inventory - Head and Neck Cancer Module.
Gunn GB; Atalar B; Mendoza TR; Cleeland CS; Selek U; Özyar E; Rosenthal DI
Balkan Med J; 2016 May; 33(3):339-43. PubMed ID: 27308079
[TBL] [Abstract][Full Text] [Related]
14. Single-item discrimination of quality-of-life-altering dysphagia among 714 long-term oropharyngeal cancer survivors: Comparison of patient-reported outcome measures of swallowing.
; Grant S; Kamal M; Mohamed ASR; Zaveri J; Barrow MP; Gunn GB; Lai SY; Lewin JS; Rosenthal DI; Wang XS; Fuller CD; Hutcheson KA
Cancer; 2019 May; 125(10):1654-1664. PubMed ID: 30633325
[TBL] [Abstract][Full Text] [Related]
15. Prospective assessment of oral mucositis and its impact on quality of life and patient-reported outcomes during radiotherapy for head and neck cancer.
Franco P; Martini S; Di Muzio J; Cavallin C; Arcadipane F; Rampino M; Ostellino O; Pecorari G; Garzino Demo P; Fasolis M; Airoldi M; Ricardi U
Med Oncol; 2017 May; 34(5):81. PubMed ID: 28386836
[TBL] [Abstract][Full Text] [Related]
16. Comparing the patients' subjective experiences of acute side effects during radiotherapy for head and neck cancer with four different patient-reported outcomes questionnaires.
Holländer-Mieritz C; Johansen J; Johansen C; Vogelius IR; Kristensen CA; Pappot H
Acta Oncol; 2019 May; 58(5):603-609. PubMed ID: 30698098
[No Abstract] [Full Text] [Related]
17. Symptom Burden Associated With Late Lower Cranial Neuropathy in Long-term Oropharyngeal Cancer Survivors.
Aggarwal P; Zaveri JS; Goepfert RP; Shi Q; Du XL; Swartz M; Gunn GB; Lai SY; Fuller CD; Hanna EY; Rosenthal DI; Lewin JS; Piller LB; Hutcheson KA
JAMA Otolaryngol Head Neck Surg; 2018 Nov; 144(11):1066-1076. PubMed ID: 30193299
[TBL] [Abstract][Full Text] [Related]
18. Risk-scoring system for predicting mucositis in patients of head and neck cancer receiving concurrent chemoradiotherapy [rssm-hn].
Suresh AV; Varma PP; Sinha S; Deepika S; Raman R; Srinivasan M; Mandapal T; Reddy CO; Anand BB
J Cancer Res Ther; 2010; 6(4):448-51. PubMed ID: 21358078
[TBL] [Abstract][Full Text] [Related]
19. Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck cancer: a prospective analysis using the University of Texas MD Anderson Cancer Center Symptom Inventory-Head and Neck Module.
Rosenthal DI; Mendoza TR; Fuller CD; Hutcheson KA; Wang XS; Hanna EY; Lu C; Garden AS; Morrison WH; Cleeland CS; Gunn GB
Cancer; 2014 Jul; 120(13):1975-84. PubMed ID: 24711162
[TBL] [Abstract][Full Text] [Related]
20. Prospective evaluation of patient reported swallow function with the Functional Assessment of Cancer Therapy (FACT), MD Anderson Dysphagia Inventory (MDADI) and the Sydney Swallow Questionnaire (SSQ) in head and neck cancer patients.
Peng LC; Hui X; Cheng Z; Bowers MR; Moore J; Cecil E; Choflet A; Thompson A; Muse M; Kiess AP; Page BR; Gourin CG; Fakhry C; Szczesniak M; Maclean J; Wu P; Cook I; McNutt TR; Quon H
Oral Oncol; 2018 Sep; 84():25-30. PubMed ID: 30115472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
